239 related articles for article (PubMed ID: 17311938)
1. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells.
Schley PD; Brindley DN; Field CJ
J Nutr; 2007 Mar; 137(3):548-53. PubMed ID: 17311938
[TBL] [Abstract][Full Text] [Related]
2. Chemical-physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation.
Corsetto PA; Cremona A; Montorfano G; Jovenitti IE; Orsini F; Arosio P; Rizzo AM
Cell Biochem Biophys; 2012 Sep; 64(1):45-59. PubMed ID: 22622660
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic Acid Incorporation Is Not Affected by Doxorubicin Chemotherapy in either Whole Cell or Lipid Raft Phospholipids of Breast Cancer Cells in vitro and Tumor Phospholipids in vivo.
Newell M; Patel D; Goruk S; Field CJ
Lipids; 2020 Sep; 55(5):549-565. PubMed ID: 32588470
[TBL] [Abstract][Full Text] [Related]
4. Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER(-) breast cancer cells.
Ewaschuk JB; Newell M; Field CJ
Lipids; 2012 Nov; 47(11):1019-30. PubMed ID: 23054549
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
Schley PD; Jijon HB; Robinson LE; Field CJ
Breast Cancer Res Treat; 2005 Jul; 92(2):187-95. PubMed ID: 15986129
[TBL] [Abstract][Full Text] [Related]
6. Protective action of n-3 fatty acids on benzo[a]pyrene-induced apoptosis through the plasma membrane remodeling-dependent NHE1 pathway.
Dendelé B; Tekpli X; Hardonnière K; Holme JA; Debure L; Catheline D; Arlt VM; Nagy E; Phillips DH; Ovrebø S; Mollerup S; Poët M; Chevanne M; Rioux V; Dimanche-Boitrel MT; Sergent O; Lagadic-Gossmann D
Chem Biol Interact; 2014 Jan; 207():41-51. PubMed ID: 24246761
[TBL] [Abstract][Full Text] [Related]
7. Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane.
Corsetto PA; Montorfano G; Zava S; Jovenitti IE; Cremona A; Berra B; Rizzo AM
Lipids Health Dis; 2011 May; 10():73. PubMed ID: 21569413
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid.
Chen W; Jump DB; Esselman WJ; Busik JV
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):18-26. PubMed ID: 17197511
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of lipid raft-associated onco-proteins via cholesterol-dependent lipid raft internalization in docosahexaenoic acid-induced apoptosis.
Lee EJ; Yun UJ; Koo KH; Sung JY; Shim J; Ye SK; Hong KM; Kim YN
Biochim Biophys Acta; 2014 Jan; 1841(1):190-203. PubMed ID: 24120917
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2.
Nikolakopoulou Z; Nteliopoulos G; Michael-Titus AT; Parkinson EK
Carcinogenesis; 2013 Dec; 34(12):2716-25. PubMed ID: 23892603
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells.
Shaikh SR; Rockett BD; Salameh M; Carraway K
J Nutr; 2009 Sep; 139(9):1632-9. PubMed ID: 19640970
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association.
Rogers KR; Kikawa KD; Mouradian M; Hernandez K; McKinnon KM; Ahwah SM; Pardini RS
Carcinogenesis; 2010 Sep; 31(9):1523-30. PubMed ID: 20525880
[TBL] [Abstract][Full Text] [Related]
13. Lipid rafts--composition, characterization, and controversies.
Calder PC; Yaqoob P
J Nutr; 2007 Mar; 137(3):545-7. PubMed ID: 17311937
[No Abstract] [Full Text] [Related]
14. Feeding long-chain n-3 polyunsaturated fatty acids to obese leptin receptor-deficient JCR:LA- cp rats modifies immune function and lipid-raft fatty acid composition.
Ruth MR; Proctor SD; Field CJ
Br J Nutr; 2009 May; 101(9):1341-50. PubMed ID: 19079834
[TBL] [Abstract][Full Text] [Related]
15. Combination of n-3 polyunsaturated fatty acids reduces atherogenesis in apolipoprotein E-deficient mice by inhibiting macrophage activation.
Takashima A; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Taketani Y; Shimabukuro M; Sata M
Atherosclerosis; 2016 Nov; 254():142-150. PubMed ID: 27744130
[TBL] [Abstract][Full Text] [Related]
16. Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells.
Irwin ME; Bohin N; Boerner JL
Cancer Biol Ther; 2011 Oct; 12(8):718-26. PubMed ID: 21775822
[TBL] [Abstract][Full Text] [Related]
17. Lipid functions in skin: Differential effects of n-3 polyunsaturated fatty acids on cutaneous ceramides, in a human skin organ culture model.
Kendall AC; Kiezel-Tsugunova M; Brownbridge LC; Harwood JL; Nicolaou A
Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt B):1679-1689. PubMed ID: 28341437
[TBL] [Abstract][Full Text] [Related]
18. A role for lipid rafts in the protection afforded by docosahexaenoic acid against ethanol toxicity in primary rat hepatocytes.
Aliche-Djoudi F; Podechard N; Collin A; Chevanne M; Provost E; Poul M; Le Hégarat L; Catheline D; Legrand P; Dimanche-Boitrel MT; Lagadic-Gossmann D; Sergent O
Food Chem Toxicol; 2013 Oct; 60():286-96. PubMed ID: 23907024
[TBL] [Abstract][Full Text] [Related]
19. Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models.
VanderSluis L; Mazurak VC; Damaraju S; Field CJ
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207553
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of omega-3 fatty acids on injury-induced epidermal growth factor receptor transactivation contribute to delayed wound healing.
Turk HF; Monk JM; Fan YY; Callaway ES; Weeks B; Chapkin RS
Am J Physiol Cell Physiol; 2013 May; 304(9):C905-17. PubMed ID: 23426968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
